Related references
Note: Only part of the references are listed.Acquired resistance to aromatase inhibitors: where we stand!
Tiago Vieira Augusto et al.
ENDOCRINE-RELATED CANCER (2018)
Disrupting a negative feedback loop drives endocrine therapy-resistant breast cancer
Charles E. Foulds
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
SIRT3 Silencing Sensitizes Breast Cancer Cells to Cytotoxic Treatments Through an Increment in ROS Production
Margalida Torrens-Mas et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Lower Beclin 1 downregulates HER2 expression to enhance tamoxifen sensitivity and predicts a favorable outcome for ER positive breast cancer
Yu Gu et al.
ONCOTARGET (2017)
A shortcut for early macrophage recruitment into tumors by activated oncogenes
Liv Austenaa et al.
GENES & DEVELOPMENT (2017)
Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6
Noritaka Yamaguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Role of steroid receptor and coregulator mutations in hormone-dependent cancers
Anna C. Groner et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells
Ali Vaziri-Gohar et al.
MOLECULAR CANCER RESEARCH (2017)
Aspirin regulation of c-myc and cyclinD1 proteins to overcome tamoxifen resistance in estrogen receptor-positive breast cancer cells
Ran Cheng et al.
ONCOTARGET (2017)
Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases
Helen Ha et al.
THERANOSTICS (2017)
Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
Ganesh V. Raj et al.
ELIFE (2017)
ER-α36 Interactions With Cytosolic Molecular Network in Acquired Tamoxifen Resistance
Azin Teymourzadeh et al.
CLINICAL BREAST CANCER (2017)
Estrogen receptor agonists/antagonists in breast cancer therapy: A critical review
A. Jameera Begam et al.
BIOORGANIC CHEMISTRY (2017)
Essential role of Notch4/STAT3 signaling in epithelial-mesenchymal transition of tamoxifen-resistant human breast cancer
Quyen Thu Bui et al.
CANCER LETTERS (2017)
Novel insights in the regulation and function of macrophages in the tumor microenvironment
Evangelia Bolli et al.
CURRENT OPINION IN ONCOLOGY (2017)
Aggressive breast cancer in western Kenya has early onset, high proliferation, and immune cell infiltration
Rispah T. Sawe et al.
BMC CANCER (2016)
MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours
Andrew R. Green et al.
BRITISH JOURNAL OF CANCER (2016)
A Milestone Review on How Macrophages Affect Tumor Growth
Christophe Caux et al.
CANCER RESEARCH (2016)
IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo
Giacomo Casella et al.
JOURNAL OF NEUROINFLAMMATION (2016)
MEK activity controls IL-8 expression in tamoxifen-resistant MCF-7 breast cancer cells
Sangmin Kim et al.
ONCOLOGY REPORTS (2016)
COPS5 amplification and overexpression confers tamoxifen-resistance in ERα-positive breast cancer by degradation of NCoR
Renquan Lu et al.
NATURE COMMUNICATIONS (2016)
Stat3 accelerates Myc induced tumor formation while reducing growth rate in a mouse model of breast cancer
Jing-Ru Jhan et al.
ONCOTARGET (2016)
Characterization of M1/M2 Tumour-Associated Macrophages (TAMs) and Th1/Th2 Cytokine Profiles in Patients with NSCLC
S. A. Almatroodi et al.
CANCER MICROENVIRONMENT (2016)
Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy
Carly Bess Williams et al.
NPJ BREAST CANCER (2016)
M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide
Marie Genin et al.
BMC CANCER (2015)
Estrogen receptor alpha phosphorylation and its functional impact in human breast cancer
Muralidharan Anbalagan et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer
Maija Hollmen et al.
SCIENTIFIC REPORTS (2015)
Clinical significance of macrophage heterogeneity in human malignant tumors
Yoshihiro Komohara et al.
CANCER SCIENCE (2014)
Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (Review)
Rubi Viedma-Rodriguez et al.
ONCOLOGY REPORTS (2014)
Tumor-Associated Macrophages are Correlated with Tamoxifen Resistance in the Postmenopausal Breast Cancer Patients
Qi-jia Xuan et al.
PATHOLOGY & ONCOLOGY RESEARCH (2014)
Nuclear factor-κB plays a critical role in both intrinsic and acquired resistance against endocrine therapy in human breast cancer cells
Kumiko Oida et al.
SCIENTIFIC REPORTS (2014)
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Theerawut Chanmee et al.
CANCERS (2014)
Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology
Oscar M. Pello et al.
BLOOD (2012)
Global Characterization of the SRC-1 Transcriptome Identifies ADAM22 as an ER-Independent Mediator of Endocrine-Resistant Breast Cancer
Damian McCartan et al.
CANCER RESEARCH (2012)
Metastatic Progression with Resistance to Aromatase Inhibitors Is Driven by the Steroid Receptor Coactivator SRC-1
Jean McBryan et al.
CANCER RESEARCH (2012)
Acquired Resistance to Tamoxifen Is Associated with Loss of the Type I Insulin-like Growth Factor Receptor: Implications for Breast Cancer Treatment
Dedra H. Fagan et al.
CANCER RESEARCH (2012)
Mechanisms of FGFR3 actions in endocrine resistant breast cancer
D. C. Tomlinson et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Macrophage plasticity and polarization: in vivo veritas
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Phosphorylation of Estrogen Receptor α at Serine 118 Directs Recruitment of Promoter Complexes and Gene-Specific Transcription
Tamika T. Duplessis et al.
ENDOCRINOLOGY (2011)
Detection of mycoplasma contamination in cell substrates using reverse transcription-PCR assays
M. Peredeltchouk et al.
JOURNAL OF APPLIED MICROBIOLOGY (2011)
Regulation of cyclin D1 gene expression
Ini-Isabee Witzel et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
Tumor Necrosis Factor-a Signaling in Macrophages
Narayanan Parameswaran et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2010)
Stat3 Orchestrates Tumor Development and Progression: The Achilles' Heel of Head and Neck Cancers?
M. Masuda et al.
CURRENT CANCER DRUG TARGETS (2010)
Tumor-stromal cell interactions and opportunities for therapeutic intervention
Taturo Udagawa et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
A phosphorylation code for oestrogen receptor-α predicts clinical outcome to endocrine therapy in breast cancer
Georgios P. Skliris et al.
ENDOCRINE-RELATED CANCER (2010)
Hormone Action in the Mammary Gland
Cathrin Brisken et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Inflammation and Cancer: IL-6 and STAT3 Complete the Link
Jacqueline Bromberg et al.
CANCER CELL (2009)
Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
Heehyoung Lee et al.
CANCER CELL (2009)
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Francesco Colotta et al.
CARCINOGENESIS (2009)
Reciprocal regulation of 17 beta-estradiol, interleukin-6 and interleukin-8 during growth and progression of epithelial ovarian cancer
Jie Yang et al.
CYTOKINE (2009)
NF-κB and Estrogen Receptor α Interactions: Differential Function in Estrogen Receptor-Negative and -Positive Hormone-independent Breast Cancer Cells
Nathalie Gionet et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Biological determinants of endocrine resistance in breast cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2009)
Preclinical modeling of endocrine response and resistance: Focus on aromatase inhibitors
Luciana F. Macedo et al.
CANCER (2008)
Tamoxifen stimulates the growth of cyclin D1 - Overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3
Yuki Ishii et al.
CANCER RESEARCH (2008)
Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity
Ross S. Thomas et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2008)
CBP is a dosage-dependent regulator of nuclear factor-κB suppression by the estrogen receptor
Kendall W. Nettles et al.
MOLECULAR ENDOCRINOLOGY (2008)
The wolf in sheep's clothing: the role of interieukin-6 in immunity, inflammation and cancer
Willscott E. Naugler et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer
Looket Dihge et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
The breast cancer continuum in hormone-receptor-positive breast cancer in postmenopausal women: evolving management options focusing on aromatase inhibitors
H. S. Rugo
ANNALS OF ONCOLOGY (2008)
Selective estrogen-receptor modulators and antihormonal resistance in breast cancer
V. Craig Jordan et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Nuclear receptor coregulators: Judges, juries, and executioners of cellular regulation
David M. Lonard et al.
MOLECULAR CELL (2007)
Targeting the tumor microenvironment
Paraic A. Kenny et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy- : A phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)
Uwe Wagner et al.
GYNECOLOGIC ONCOLOGY (2007)
Oestrogen receptor negative breast cancers exhibit high cytokine content
Carine Chavey et al.
BREAST CANCER RESEARCH (2007)
Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer
V. Craig Jordan et al.
STEROIDS (2007)
Phosphorylation of ERα at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERα phosphorylation in breast cancer progression
N. Sarwar et al.
ENDOCRINE-RELATED CANCER (2006)
The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients
Neora Yaal-Hahoshen et al.
CLINICAL CANCER RESEARCH (2006)
Nuclear factor-κB in cancer development and progression
Michael Karin
NATURE (2006)
Fulvestrant ('Faslodex'): Current and future role in breast cancer management
A Howell
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway
P Zhu et al.
CELL (2006)
Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis
J Condeelis et al.
CELL (2006)
Persistent activation of Stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells
T Gritsko et al.
CLINICAL CANCER RESEARCH (2006)
Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptionaf response
Michael G. Rosenfeld et al.
GENES & DEVELOPMENT (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Estrogen receptors alfa (ERα) and beta (ERβ) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11
LA Helguero et al.
ONCOGENE (2005)
Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E
AJ Butt et al.
ENDOCRINE-RELATED CANCER (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Expanding functional diversity of the coactivators
DM Lonard et al.
TRENDS IN BIOCHEMICAL SCIENCES (2005)
A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer - Cancer and Leukemia Group B Study (9235)
EF McClay et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2005)
Recruitment of distinct chromatin-modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo
XF Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
NF-KB activation in human breast cancer specimens and its role in cell proliferation and apoptosis
DK Biswas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Use of tamoxifen in the treatment of malignant melanoma - Systematic review and melaanalysis of randomized controlled trials
MB Lens et al.
CANCER (2003)
Increasing the yield of human mononuclear cells and low serum conditions for in vitro generation of macrophages with M-CSF
A Plesner
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Opposing action of estrogen receptors α and β on cyclin D1 gene expression
MM Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Effects of selective estrogen receptor modulators (SERMs) on coactivator nuclear receptor (NR) box binding to estrogen receptors
KS Bramlett et al.
MOLECULAR GENETICS AND METABOLISM (2002)
Tumor necrosis factor or tumor promoting factor?
F Balkwill
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
Combinatorial control of gene expression by nuclear receptors and coregulators
NJ McKenna et al.
CELL (2002)
The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies
L Bingle et al.
JOURNAL OF PATHOLOGY (2002)
Reciprocal antagonism between estrogen receptor and NF-κB activity in vivo
MJ Evans et al.
CIRCULATION RESEARCH (2001)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Share Paper
